Federal contract award
75A50124F61001
OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
| Parent award / vehicle | 75A50123D00003 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $32.0M |
| Current contract value | $32.0M |
| Potential contract value / ceiling | $32.0M |
| Start date | Dec 12, 2023 |
| Current end date | Dec 31, 2027 |
| Potential end date | Dec 31, 2027 |
| Latest award activity | Feb 23, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 23, 2026 | P00006 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE. |
| Oct 29, 2025 | P00005 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ATTACHMENT 1, SECTION 7: TASK ORDER POINTS OF CONTACT. |
| Apr 23, 2025 | P00004 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO DELETE THE STATEMENT OF OBJECTIVES (SOO) DATED 12/11/2023 IN ITS ENTIRETY AND REPLACE IT WITH THE REVISED SOO DATED 04/23/2025. |
| Jan 8, 2025 | P00003 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTION 7: TASK ORDER POINTS OF CONTACT BY CHANGING THE HHS/ASPR OTHER TRANSACTION AUTHORITY OFFICER (OTAO) FROM CHRISTOPHER WEAVER TO LORI FISCHER. |
| Nov 15, 2024 | P00002 | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO TRANSFER TASK ORDER 75A50124F61001 FROM ASPR/BARDA/PCI TO ASPR INDUSTRIAL BASE MANAGEMENT AND SUPPLY CHAIN (IBMSC) |
| Sep 20, 2024 | P00001 | $0 | OTHER TRANSACTION: TO (1) INCORPORATE REVISED OT BASE AGREEMENT 75A50123D00003, DATED AUGUST 29, 2024, BY REFERENCE; AND (2) REVISE THE COMPLETION DATE ON THE ORDER, INCLUDING LINES 1 AND 2, TO 09/30/2026. |
| Dec 12, 2023 | 0 | $32.0M | OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM |
Estimated positioning window
Dec 31, 2026 – Jun 30, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2027-12-31 (425 days from calculation)
- +25 points
- 8 historical awards in this buyer and category group
- +15 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-02-23
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.